<SEC-DOCUMENT>0001213900-26-055510-index.html : 20260513
<SEC-HEADER>0001213900-26-055510.hdr.sgml : 20260513
<ACCEPTANCE-DATETIME>20260513092703
ACCESSION NUMBER:		0001213900-26-055510
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20260513
FILED AS OF DATE:		20260513
DATE AS OF CHANGE:		20260513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Polyrizon Ltd.
		CENTRAL INDEX KEY:			0001893645
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42375
		FILM NUMBER:		26971319

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		HAPNINA ST 8
		CITY:			RA'ANANA
		PROVINCE COUNTRY:   	L3
		ZIP:			4321545
		BUSINESS PHONE:		972-54-7979668

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		HAPNINA ST 8
		CITY:			RA'ANANA
		PROVINCE COUNTRY:   	L3
		ZIP:			4321545
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0290540-6k_polyrizon.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
Document 1 - file: ea0290540-6k_polyrizon.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea029054002ex99-1.htm
<DESCRIPTION>PRESS RELEASE TITLED: "POLYRIZON ADVANCES TOWARDS HUMAN CLINICAL TRIALS: SECURES FIRST U.S. CLINICAL SITE FOR NASARIXTM ALLERGY BLOCKER CLINICAL TRIAL"
<TEXT>
Document 2 - file: ea029054002ex99-1.htm

</DOCUMENT>
</SEC-DOCUMENT>